Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Tardy

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Drugs & Aging|August 5, 2000
Heparin-Induced thrombocytopenia: minimising the risks in the elderly patientB Tardy-Poncet, B Tardy
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 13, 2010
Difference in TFPI levels between haemophilia A and B patientsB Tardy-Poncet, M Piot, C Chapelle, et al.
Thrombosis and Haemostasis|October 6, 1998
Fatal danaparoid-sodium induced thrombocytopenia and arterial thrombosesB Tardy, B Tardy-Poncet, A Viallon, et al.
Thrombosis and Haemostasis|September 24, 1999
Lower limb veins should be systematically explored in patients with isolated heparin-induced thrombocytopeniaB Tardy, B Tardy-Poncet, P Fournel, et al.
Journal of Thrombosis and Haemostasis : JTH|June 8, 2011
Experts' opinion or the serotonin release assay as a gold standard for the diagnosis of heparin-induced thrombocytopenia (HIT)?B Tardy, E Presles, M Akrour, et al.
Therapie|September 1, 1990
[Thrombopenia caused by low molecular weight heparin]B Tardy, Y Page, B Tardy-Poncet, et al.
Cancer|May 1, 1993
Low molecular weight heparin for Hickman catheter-induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantationB Tardy, B Tardy-Poncet, Y Page, et al.
La Revue De Medecine Interne|October 17, 2012
[Newly diagnosed multiple myeloma: Do we need to propose thromboprophylaxis?]E Chalayer, K Augeul-Meunier, B Tardy-Poncet, et al.
Intensive Care Medicine|April 8, 2009
Danaparoid cross-reactivity with heparin-induced thrombocytopenia antibodies: report of 12 casesB Tardy-Poncet, M Wolf, D Lasne, et al.
Chest|June 23, 1999
Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopeniaB Tardy-Poncet, B Tardy, J Reynaud, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Drugs & Aging|August 5, 2000
Heparin-Induced thrombocytopenia: minimising the risks in the elderly patientB Tardy-Poncet, B Tardy
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 13, 2010
Difference in TFPI levels between haemophilia A and B patientsB Tardy-Poncet, M Piot, C Chapelle, et al.
Thrombosis and Haemostasis|October 6, 1998
Fatal danaparoid-sodium induced thrombocytopenia and arterial thrombosesB Tardy, B Tardy-Poncet, A Viallon, et al.
Thrombosis and Haemostasis|September 24, 1999
Lower limb veins should be systematically explored in patients with isolated heparin-induced thrombocytopeniaB Tardy, B Tardy-Poncet, P Fournel, et al.
Journal of Thrombosis and Haemostasis : JTH|June 8, 2011
Experts' opinion or the serotonin release assay as a gold standard for the diagnosis of heparin-induced thrombocytopenia (HIT)?B Tardy, E Presles, M Akrour, et al.
Therapie|September 1, 1990
[Thrombopenia caused by low molecular weight heparin]B Tardy, Y Page, B Tardy-Poncet, et al.
Cancer|May 1, 1993
Low molecular weight heparin for Hickman catheter-induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantationB Tardy, B Tardy-Poncet, Y Page, et al.
La Revue De Medecine Interne|October 17, 2012
[Newly diagnosed multiple myeloma: Do we need to propose thromboprophylaxis?]E Chalayer, K Augeul-Meunier, B Tardy-Poncet, et al.
Intensive Care Medicine|April 8, 2009
Danaparoid cross-reactivity with heparin-induced thrombocytopenia antibodies: report of 12 casesB Tardy-Poncet, M Wolf, D Lasne, et al.
Chest|June 23, 1999
Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopeniaB Tardy-Poncet, B Tardy, J Reynaud, et al.
Pageof 11